Positive initial vaccine trials from the company Moderna boosted risk sentiment this week as the market became optimistic that COVID-19 could be restrained more quickly than anticipated. This resulted in strength across the commodity currency block in AUD, NZD, CAD, and weakness in the USD midweek. The key aspect to remember about our present financial crisis is that it is primarily a medical crisis rather than a financial one. This means that a medical solution can be the answer that the market needs to put in a swift recovery. Expect Moderna's vaccine to be closely followed for further data releases going forward.
Key events from the past week
-
EURO: Franco-German proposal, Europe, Tues, May 19. The euro extended gains midweek boosted by a Franco-German proposal for a common fund that in-crease hopes of a European fiscal union. USD weakness on risk positive flows further boosted EURUSD demand midweek.
-
US-China: Trade war tensions return, All week. Tensions have returned between the US and China after the US Senate passed a bill potentially causing some Chinese companies to de-list from the US Stock exchanges. This caused some risk-off flows going into Thursday which supports the DXY above 99.00
-
Moderna Vaccine: Will it work? Note that vaccine hopes were questioned on Tuesday. STAT news reported that Moderna's COVID-19 vaccine did not produce critical data to properly assess the vaccine. However, this news was shaken off by Wednesday as the market focused on the optimism of a promising vaccine.
Key events for the coming week
-
US-China: Further trade disputes, May 25. In a light data slate next week there is unlikely to be many market-moving economic releases. However, of much greater concern will be if the negative US-China trade rhetoric turns into more action. If this happens then risk sentiment could easily become negative again.
-
XAU/USD: Short term demand for gold to fall? With vaccine hopes gold's surge higher was halted at $1750. If the positive sentiment continues next week will gold head back down towards support at $1725 or be able to keep grinding higher to $1800?
-
Coronavirus: Watch out for the latest virus news. Positive vaccine news from Moderna will continue to support risk, but keep aware that any negative news concerning the vaccine will result in risk-off markets returning.
Our products and commentary provides general advice that do not take into account your personal objectives, financial situation or needs. The content of this website must not be construed as personal advice.
Recommended Content
Editors’ Picks
AUD/USD holds above 0.6500 in thin trading
The Australian Dollar managed to recover ground against its American rival after AUD/USD fell to 0.6484. The upbeat tone of Wall Street underpinned the Aussie despite broad US Dollar strength and tepid Australian data.
EUR/USD comfortable below 1.0800 lower lows at sight
The EUR/USD pair lost ground on Thursday and settled near a fresh March low of 1.0774. Strong US data and hawkish Fed speakers comments lead the way ahead of the release of the US PCE Price Index on Friday.
Gold pulls away from daily highs, holds above $2,200
Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Thursday. The benchmark 10-year US Treasury bond yield stays near 4.2% after upbeat US data and makes it difficult for XAU/USD to gather further bullish momentum.
Google starts indexing Bitcoin addresses
Bitcoin address data is live on Google search results after users realized on Thursday that the tech giant started indexing Bitcoin blockchain data. However, mixed reactions have followed the tech giant's reversed stance on the cryptocurrency.
A Hollywood ending for fourth quarter GDP
The latest revisions put Q4 GDP at 3.4%, the second fastest quarterly growth rate in two years. Much of the upside was attributable to stronger consumer spending, yet fresh profits data affirmed it was a good quarter for the bottom line as well with profits up by the most since the Q2-2022.